Jazz Pharmaceuticals (JAZZ) Return on Invested Capital (2016 - 2023)
Historic Return on Invested Capital for Jazz Pharmaceuticals (JAZZ) over the last 14 years, with Q3 2025 value amounting to 0.0%.
- Jazz Pharmaceuticals' Return on Invested Capital fell 800.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.09% for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Invested Capital is 0.0%, which was down 800.0% from 0.0% recorded in Q2 2025.
- In the past 5 years, Jazz Pharmaceuticals' Return on Invested Capital registered a high of 0.1% during Q1 2021, and its lowest value of 0.06% during Q3 2021.
- In the last 5 years, Jazz Pharmaceuticals' Return on Invested Capital had a median value of 0.01% in 2022 and averaged 0.03%.
- In the last 5 years, Jazz Pharmaceuticals' Return on Invested Capital tumbled by -1100bps in 2021 and then skyrocketed by 900bps in 2023.
- Over the past 5 years, Jazz Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.05% in 2021, then plummeted by -109bps to 0.0% in 2022, then skyrocketed by 2097bps to 0.09% in 2023, then fell by -4bps to 0.08% in 2024, then tumbled by -104bps to 0.0% in 2025.
- Its Return on Invested Capital stands at 0.0% for Q3 2025, versus 0.0% for Q2 2025 and 0.08% for Q4 2024.